Roivant Sciences Ltd. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Roivant Sciences Ltd. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2020 to Q3 2024.
  • Roivant Sciences Ltd. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$230M, a 24.4% increase year-over-year.
  • Roivant Sciences Ltd. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $4.81B.
  • Roivant Sciences Ltd. annual Net Income (Loss) Attributable to Parent for 2023 was $4.35B.
  • Roivant Sciences Ltd. annual Net Income (Loss) Attributable to Parent for 2022 was -$1.01B, a 19.4% decline from 2021.
  • Roivant Sciences Ltd. annual Net Income (Loss) Attributable to Parent for 2021 was -$845M, a 4.45% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $4.81B -$230M +$74.1M +24.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $4.74B $95.3M +$387M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $4.35B -$151M -$117M -350% Jan 1, 2024 Mar 31, 2024 10-K 2024-05-30
Q4 2023 $4.47B $5.1B +$5.45B Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-13
Q3 2023 -$982M -$304M -$12.7M -4.37% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$969M -$292M +$40M +12.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$1.01B -$33.6M +$236M +87.6% Jan 1, 2023 Mar 31, 2023 10-K 2024-05-30
Q4 2022 -$1.25B -$352M -$67.5M -23.7% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-13
Q3 2022 -$1.18B -$292M -$83.1M -39.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$1.09B -$332M -$250M -304% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$845M -$270M +$240M +47% Jan 1, 2022 Mar 31, 2022 10-K 2023-06-28
Q4 2021 -$1.08B -$285M -$23.5M -9.01% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-13
Q3 2021 -$1.06B -$208M -$173M -489% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$888M -$82.2M -$78.9M -2434% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$809M -$510M Jan 1, 2021 Mar 31, 2021 10-K 2022-06-28
Q4 2020 -$261M Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 -$35.4M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$3.24M Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.